REVELATION BIOSCIENCES, INC. Accrued Liabilities, Current
REVELATION BIOSCIENCES, INC. (REVB) had Accrued Liabilities, Current of $759.94 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities, Current $759.94K.
- 2026-03-31: Accrued Liabilities, Current $468.08K.
- 2025-12-31: Accrued Liabilities, Current $1.40M.
- 2025-09-30: Accrued Liabilities, Current $819.38K.
USD
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $759.94K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $468.08K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $1.40M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $819.38K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $739.63K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $463.63K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $1.13M 10-K · filed 2026-02-26 | $1.13M 10-K · filed 2025-03-06 |
| 2024-09-30 | $934.37K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $8.45M 10-Q/A · filed 2024-09-23 | |
| 2024-03-31 | $620.28K 10-Q/A · filed 2024-09-23 | |
| 2023-12-31 | $1.15M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $1.02M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $496.87K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $973.92K 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $985.50K 10-K/A · filed 2024-09-23 | |
| 2022-09-30 | $996.45K 10-Q · filed 2022-11-10 | |
| 2022-09-27 | $1.60M 10-K/A · filed 2024-09-23 | |
| 2022-06-30 | $2.17M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $3.71M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $1.53M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $33.77K 10-K/A · filed 2021-06-16 | |
| 2020-09-30 | $61.25K 10-Q · filed 2020-11-16 | |
| 2019-12-31 | $16.31K 10-K/A · filed 2021-06-16 |
GBP
| Period end | Accrued Liabilities, Current |
|---|---|
| 2022-09-27 | 1.60M GBP 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |